Procitil Injection is a medication that contains Prochlorperazine, a phenothiazine class drug. It is primarily used to treat: 1. Severe Nausea and Vomiting Procitil is effective in managing nausea and vomiting caused by various conditions, including: • Post-operative recovery • Chemotherapy-induced nausea • Gastrointestinal disorders 2. Psychotic Disorders Prochlorperazine, the active ingredient in Procitil, has antipsychotic properties and is used to manage symptoms of: • Schizophrenia • Delirium • Severe anxiety 3. Vertigo and Dizziness It helps alleviate dizziness and balance issues associated with inner ear problems. 4. Severe Anxiety Procitil can be used in the short-term management of severe anxiety when other treatments are not effective. 5. Hiccups In some cases, Procitil is used to treat persistent and severe hiccups. Administration Procitil Injection is administered intravenously or intramuscularly by a healthcare professional. The dosage and frequency depend on the specific condition being treated and the patient's response to therapy. Side Effects Common side effects may include: • Drowsiness or sedation • Dizziness • Dry mouth • Constipation • Blurry vision • Muscle stiffness or tremors • Serious side effects are rare but can include: • Severe allergic reactions • Neuroleptic malignant syndrome (a life-threatening condition) • Tardive dyskinesia (involuntary movements) If you experience any unusual symptoms, contact your healthcare provider immediately. Precautions Before using Procitil Injection, inform your doctor if you have: • Allergies to prochlorperazine or other phenothiazines • Liver or kidney disease • Heart problems • Seizure disorders • Parkinson's disease • Pregnancy or breastfeeding status

Ondican 4 Injection, also known by the generic name Ondansetron 4 mg Injection, is an antiemetic medication primarily used to prevent and treat nausea and vomiting associated with various medical conditions and treatments. Common Uses 1. Chemotherapy-Induced Nausea and Vomiting (CINV): Ondican 4 is administered to prevent nausea and vomiting caused by chemotherapy. It is typically given 30 minutes before the start of chemotherapy sessions. 2. Radiation Therapy-Induced Nausea and Vomiting: It is used to prevent nausea and vomiting associated with radiation therapy, usually administered 1–2 hours before treatment. 3. Postoperative Nausea and Vomiting (PONV): Ondican 4 helps prevent and treat nausea and vomiting following surgery. It is administered immediately before or within 2 hours after surgery. 4. Other Causes of Nausea and Vomiting: It may also be used to manage nausea and vomiting due to other causes, such as gastroenteritis or certain medical conditions. Mechanism of Action Ondican 4 works by blocking the action of serotonin, a chemical in the body that can trigger nausea and vomiting. By inhibiting serotonin receptors in the brain and gastrointestinal tract, it effectively prevents these symptoms. Administration Ondican 4 Injection is administered intravenously (IV) by a healthcare professional in a hospital or clinic setting. The dosage and timing depend on the specific condition being treated and the patient's medical history. Side Effects Common side effects may include: • Headache • Constipation • Dizziness • Fatigue • Injection site reactions These side effects are generally mild and temporary. However, if they persist or worsen, consult your healthcare provider. Precautions Before receiving Ondican 4, inform your doctor if you have: • Liver disease • Heart problems • Electrolyte imbalances • Blockage in the stomach or intestines Additionally, disclose any other medications you are taking, as interactions may occur. Pregnant or breastfeeding individuals should consult their healthcare provider before use.

Zyrop 5000IU injection contains active components such as Recombinant human erythropoietin alfa/epoetin alfa. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication treats anemia caused by chronic kidney disease (CKD), cancer chemotherapy, or HIV infection treatment with zidovudine. It also reduces the need for red blood cell transfusions in patients at high risk for blood loss due to planned surgery or other procedures. Zyrop 5000IU injection should not be used in patients with hypersensitivity to it or any of its components, uncontrolled hypertension, active thrombotic microangiopathy (TMA), pure red cell aplasia (PRCA), uncontrolled seizures, pregnancy, or lactation. It should also be used cautiously in patients with a history of blood clots, heart disease, stroke, kidney disease, liver disease, thalassemia, sickle cell anemia, myelodysplastic syndrome, leukemia, or cancer. It should only be used in children under 18 if the benefits outweigh the risks. Older adults taking this medication should be closely monitored for side effects. Before starting this medication, it is important to talk to your doctor about the risks and benefits of Zyrop 5000IU injection.

DARCEPT 40MG INJECTION belongs to the class of medication called 'blood-forming agent' primarily used to treat anaemia (low red blood cell count) in person with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer (except for bone marrow or blood cells' cancer). DARCEPT 40MG INJECTION helps to reverse anaemia and reduce the need for blood transfusion. Anaemia occurs when the body has a lower amount of red blood cells or haemoglobin. In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia. DARCEPT 40MG INJECTION contains a protein 'Darbepoetin alfa' which works by providing signals to the bone marrow to make more red blood cells. DARCEPT 40MG INJECTION is a biologic response modifier and erythropoiesis-stimulating protein. In chronic kidney disease, when the kidney fails to produce sufficient 'erythropoietin protein' which aids in the formation of red blood cells, DARCEPT 40MG INJECTION stimulates the production of this protein in the bone marrow. DARCEPT 40MG INJECTION will be injected by the healthcare provider. Do not self-administer. The most common side effects of DARCEPT 40MG INJECTION are shortness of breath, cough, low blood pressure during dialysis, headache, body aches, diarrhoea, injection site pain and abdominal pain. Most of these sides effects of DARCEPT 40MG INJECTION do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Doxorubin 10mg Injection is a chemotherapy drug containing the active constituent doxorubicin. It belongs to the medication class known as cytotoxic agents. It treats many types of cancers, such as lung, breast, blood, bladder, stomach, etc. It may be given alone or in combination with other anticancer medicines. Cancer is a condition in which cells multiply uncontrolled and abnormally. Before starting treatment with Doxorubin 10mg Injection, it is very important to tell your physician if you have or had any history of severe heart disorders, liver disorders, and hypersensitivity. Notify your doctor if you are taking or have ever received certain cancer chemotherapy medications. Avoid live vaccines during the treatment.

Doxorubin 50mg Injection is a chemotherapy drug containing the active constituent doxorubicin. It belongs to the medication class known as cytotoxic agents. It treats many types of cancers, such as lung, breast, blood, bladder, stomach, etc. It may be given alone or in combination with other anticancer medicines. Cancer is a condition in which cells multiply uncontrolled and abnormally. Before starting treatment with Doxorubin 50mg Injection, it is very important to tell your physician if you have or had any history of severe heart disorders, liver disorders, and hypersensitivity. Notify your doctor if you are taking or have ever received certain cancer chemotherapy medications. Avoid live vaccines during the treatment.

Zynesp 100mcg injection contains the active ingredient Darbepoetin Alfa. It is an antineoplastic drug that belongs to the class of medications called hematopoietic growth factors. It is used to treat anemia (lower than normal RBC) in people with chronic kidney disease. It is also indicated to treat anemia caused by chemotherapy in people with certain types of cancer. The symptoms of anemia are fatigue, weakness, and shortness of breath. Do not take Zynesp 100mcg injection if you are allergic to Darbepoetin alfa or any other ingredients and have uncontrolled blood pressure. Inform your physician if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergy to latex or hepatitis C. Inform your physician if you are pregnant or breastfeeding. If you have severe headache, dizziness, drowsiness, confusion, problems with your eyesight, nausea, vomiting, or seizures after taking Zynesp 100mcg injection, inform your physician immediately and seek medical advice. This medicine's most common side effects are hypertension, shortness of breath, swelling in the legs, and cough.

Zynesp 200 mcg Injection belongs to the class of medication called 'blood-forming agent' primarily used to treat anaemia (low red blood cell count) in person with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer (except for bone marrow or blood cells' cancer). Zynesp 200 mcg Injection helps to reverse anaemia and reduce the need for blood transfusion. Anaemia occurs when the body has a lower amount of red blood cells or haemoglobin. In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia. Zynesp 200 mcg Injection contains a protein 'Darbepoetin alfa' which works by providing signals to the bone marrow to make more red blood cells. Zynesp 200 mcg Injection is a biologic response modifier and erythropoiesis-stimulating protein. In chronic kidney disease, when the kidney fails to produce sufficient 'erythropoietin protein' which aids in the formation of red blood cells, Zynesp 200 mcg Injection stimulates the production of this protein in the bone marrow. Zynesp 200 mcg Injection will be injected by the healthcare provider. Do not self-administer. The most common side effects of Zynesp 200 mcg Injection are shortness of breath, cough, low blood pressure during dialysis, headache, body aches, diarrhoea, injection site pain and abdominal pain. Most of these sides effects of Zynesp 200 mcg Injection do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor. If you have uncontrolled/untreated high blood pressure or red cell aplasia (a type of anaemia) due to darbepoetin alfa or epoetin alfa, please inform your doctor before taking Zynesp 200 mcg Injection to avoid any complications. Also, mention all the other medications you are taking to affect the way Zynesp 200 mcg Injection works. Inform your doctor immediately, if you feel weak, lightheaded, tired, or short of breath, or if your skin looks pale as it may be signs that the body has stopped responding to Zynesp 200 mcg Injection .

Bioposide 100mg injection is an anticancer drug with the ingredient Etoposide. It belongs to the medication class known as cytostatic. It is used to treat certain types of cancers such as testicular cancer, small-cell lung cancer, acute myeloid leukemia (blood cancer), tumor in the lymphatic system (Hodgkin’s lymphoma, non-Hodgkin’s lymphoma), and ovarian cancer in adults. Talk to your doctor if you had or currently having radiotherapy or chemotherapy. Report to your doctor if you have any infections or low levels of protein (albumin) in your blood. Bioposide 100mg Injection should not be taken if you have recently been vaccinated with yellow fever or any live vaccines. Before starting treatment with this medicine, it is very important to tell your physician if you currently or previously had any medical conditions of kidney problems or liver disorders. Both women and men should use effective birth control during the treatment and at least 6 months after the last dose. In men, it is recommended not to father a child during and up to 6 months after the treatment. So it is advised to get suggestions about fertility concerns from your doctor. Administration of Bioposide 100mg injection may cause a reduction in the level of blood cells and increase the risk of developing infections. So, your doctor may perform blood tests regularly to monitor your kidney and liver function. It is unknown whether it is safe to use on a child.